Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tranexamic acid (cyklokapron) (1 trial)
dinoprostone (prostin e2) (1 trial)
rimabotulinumtoxinB (Myobloc) (1 trial)
Aneurysm (Phase 3)
Aortic Aneurysm (Phase 3)
Aortic Aneurysm, Abdominal (Phase 3)
Trials (3 total)
Trial APIs (3 total)